University Of Birmingham
Clinical trials sponsored by University Of Birmingham, explained in plain language.
-
Poop pills could tame rare liver disease
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can help people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD). About 58 adults will receive either FMT or a placebo. The goal is to see if FMT can lower liver enzyme levels and improve s…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:27 UTC
-
Cannabis drug could extend life in aggressive brain cancer
Disease control Recruiting nowThis study tests whether adding a cannabis-based mouth spray (Nabiximols) to standard chemotherapy can help people with a returning, aggressive brain tumor called glioblastoma live longer. About 120 adults whose tumor has returned after initial treatment will be randomly assigned…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New hope for lymphoma patients: REFRACT trial tests smarter therapies
Disease control Recruiting nowThis study is for people with relapsed or refractory follicular lymphoma, a type of blood cancer that has come back or not responded to treatment. It compares new experimental therapies to the current standard treatment to see which works better. About 284 adults will take part, …
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New trial aims to make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis study is for people with blood cancers like leukemia or lymphoma who need a stem cell transplant from an unrelated donor. It compares two ways to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. One method uses a d…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:16 UTC
-
New drug ruxolitinib takes on standard therapies in blood cancer trial
Disease control Recruiting nowThis study tests whether the drug ruxolitinib works better than standard treatments (interferon or hydroxycarbamide) for people with high-risk polycythemia vera, a blood cancer that causes too many red blood cells. About 586 adults aged 18 and older with high-risk features will b…
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New hope for kids with tough lymphoma: global trial tests smarter drugs
Disease control Recruiting nowThis study is for children and young people with B-cell non-Hodgkin lymphoma that has come back or not responded to treatment. Current treatments cure only about 30% of these patients and have severe side effects. The trial will test several new medicines, alone or with chemother…
Phase: PHASE2, PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New hope for kids with Tough-to-Treat cancer: BEACON2 trial launches
Disease control Recruiting nowThis study tests new combinations of drugs for children and young adults whose neuroblastoma has come back or not responded to standard treatment. About 160 participants will receive one of three treatment regimens to see which works best and is safest. The goal is to improve sur…
Phase: PHASE1, PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Head-to-Head: which brain procedure best saves sight in IIH?
Disease control Recruiting nowThis study compares two common surgeries—CSF shunting and dural venous sinus stenting—to see which better preserves vision in adults with idiopathic intracranial hypertension (IIH) at risk of blindness. About 80 participants will be randomly assigned to one procedure and followed…
Phase: NA • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Whey protein before meals may tame blood sugar spikes in seniors with diabetes
Disease control Recruiting nowThis study looks at whether drinking whey protein before meals can help older adults (ages 75-90) with type 2 diabetes keep their blood sugar levels steadier throughout the day. Over two 7-day periods, participants will take either a whey protein drink or a placebo before each me…
Phase: NA • Sponsor: University of Birmingham • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New group therapy aims to heal birth trauma
Symptom relief Recruiting nowThis study tests a group therapy program (GTEP) for people who had a traumatic birth. Ten participants will attend online sessions and report changes in trauma symptoms, wellbeing, and bonding with their baby. The goal is to see if this approach is feasible and helpful.
Phase: NA • Sponsor: University of Birmingham • Aim: Symptom relief
Last updated May 26, 2026 03:26 UTC
-
Genetic roadmap for brain tumors: a new era of precision medicine?
Knowledge-focused Recruiting nowThis study aims to improve how brain tumors (gliomas) are diagnosed and treated by using advanced genetic testing. Researchers will build a network of UK hospitals to quickly analyze each tumor's unique genetic makeup. The goal is to match patients with targeted therapies that wo…
Sponsor: University of Birmingham • Aim: Knowledge-focused
Last updated May 26, 2026 03:23 UTC
-
Grape power: could a bowl of grapes protect your brain during stress?
Knowledge-focused Recruiting nowThis study looks at whether eating grapes rich in natural compounds called flavonoids can protect brain function, blood vessel health, and mood during mental stress in healthy young adults. Researchers will give 44 participants either high-flavonoid grape powder or a low-flavonoi…
Phase: NA • Sponsor: University of Birmingham • Aim: Knowledge-focused
Last updated May 26, 2026 03:04 UTC